Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Concise review: Emerging concepts in clinical targeting of cancer stem cells.

Rasheed ZA, Kowalski J, Smith BD, Matsui W.

Stem Cells. 2011 Jun;29(6):883-7. doi: 10.1002/stem.648. Review.

2.

Heterogeneity and targeting of pancreatic cancer stem cells.

Penchev VR, Rasheed ZA, Maitra A, Matsui W.

Clin Cancer Res. 2012 Aug 15;18(16):4277-84. doi: 10.1158/1078-0432.CCR-11-3112. Review.

3.

Biological and clinical relevance of stem cells in pancreatic adenocarcinoma.

Rasheed ZA, Matsui W.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:15-8. doi: 10.1111/j.1440-1746.2011.07015.x. Review.

4.

Targeting CSC-related miRNAs for cancer therapy by natural agents.

Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali S, Banerjee S, Kong D, Sarkar FH.

Curr Drug Targets. 2012 Dec;13(14):1858-68. Review.

5.

Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.

Hong IS, Lee HY, Nam JS.

Recent Pat Anticancer Drug Discov. 2015;10(1):2-22. Review.

PMID:
25479037
6.

Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.

Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH.

Curr Protoc Pharmacol. 2013 Jun;Chapter 14:Unit 14.25. doi: 10.1002/0471141755.ph1425s61. Review.

7.

Cancer stem cells: relevance to SCT.

Lin T, Jones RJ, Matsui W.

Bone Marrow Transplant. 2009 Apr;43(7):517-23. doi: 10.1038/bmt.2009.19. Epub 2009 Feb 23. Review.

8.

Targeting Cancer Stem Cells: Promises and Challenges.

Kuhlmann JD, Hein L, Kurth I, Wimberger P, Dubrovska A.

Anticancer Agents Med Chem. 2016;16(1):38-58. Review.

PMID:
26179271
9.

MicroRNAs and cancer stem cells: the sword and the shield.

Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG.

Oncogene. 2014 Oct 16;33(42):4967-77. doi: 10.1038/onc.2013.492. Epub 2013 Nov 18. Review.

PMID:
24240682
10.

Cancer stem cells: a new framework for the design of tumor therapies.

Garvalov BK, Acker T.

J Mol Med (Berl). 2011 Feb;89(2):95-107. doi: 10.1007/s00109-010-0685-3. Epub 2010 Oct 2. Review.

PMID:
20890588
11.

Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.

Krishnamurthy S, Ke X, Yang YY.

Nanomedicine (Lond). 2015 Jan;10(1):143-60. doi: 10.2217/nnm.14.154. Review.

PMID:
25597774
12.

Targeting cancer stem cells.

Kvinlaug BT, Huntly BJ.

Expert Opin Ther Targets. 2007 Jul;11(7):915-27. Review.

PMID:
17614760
13.

Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.

Malhi S, Gu X.

Expert Opin Drug Deliv. 2015 Jul;12(7):1177-201. doi: 10.1517/17425247.2015.998648. Epub 2015 Jan 20. Review.

PMID:
25601619
14.

Complexity of cancer stem cells.

Sugihara E, Saya H.

Int J Cancer. 2013 Mar 15;132(6):1249-59. doi: 10.1002/ijc.27961. Epub 2012 Dec 17. Review.

15.

Lung cancer stem cells: The root of resistance.

MacDonagh L, Gray SG, Breen E, Cuffe S, Finn SP, O'Byrne KJ, Barr MP.

Cancer Lett. 2016 Mar 28;372(2):147-56. doi: 10.1016/j.canlet.2016.01.012. Epub 2016 Jan 18. Review.

PMID:
26797015
16.

New approaches to target cancer stem cells: current scenario.

Insan MB, Jaitak V.

Mini Rev Med Chem. 2014 Jan;14(1):20-34. Review.

PMID:
24195662
17.

Die hard: are cancer stem cells the Bruce Willises of tumor biology?

Fábián A, Barok M, Vereb G, Szöllosi J.

Cytometry A. 2009 Jan;75(1):67-74. doi: 10.1002/cyto.a.20690. Review.

18.

Concise review: Cancer stem cells and minimal residual disease.

Ghiaur G, Gerber J, Jones RJ.

Stem Cells. 2012 Jan;30(1):89-93. doi: 10.1002/stem.769. Review.

19.

Cancer stem cells and their potential implications for the treatment of solid tumors.

Grotenhuis BA, Wijnhoven BP, van Lanschot JJ.

J Surg Oncol. 2012 Aug 1;106(2):209-15. doi: 10.1002/jso.23069. Epub 2012 Feb 27. Review.

PMID:
22371125
20.

Cancer stem cells as the relevant biomass for drug discovery.

Winquist RJ, Furey BF, Boucher DM.

Curr Opin Pharmacol. 2010 Aug;10(4):385-90. doi: 10.1016/j.coph.2010.06.008. Epub 2010 Jul 12. Review.

PMID:
20630801

Supplemental Content

Support Center